Allosteric effects of a monoclonal antibody against thrombin exosite II

被引:31
作者
Colwell, NS
Blinder, MA
Tsiang, M
Gibbs, CS
Bock, PE
Tollefsen, DM
机构
[1] Washington Univ, Sch Med, Div Hematol, Dept Internal Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Gilead Sci Inc, Foster City, CA 94404 USA
[4] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA
关键词
D O I
10.1021/bi980925f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously isolated a monoclonal antithrombin Ige from a patient with multiple myeloma [Colwell et al. (1997) Br. J. Haematol. 97, 219-226]. Using a panel of 55 surface mutants of recombinant thrombin, we now show that the epitope for the IgG most likely includes Arg-101, Arg-233, and Lys-236 in exosite II. The IgG affects the rate at which thrombin cleaves various peptide p-nitroanilide substrates with arginine in the P1 position, increasing the k(cat) for substrates with a P2 glycine residue but generally decreasing the k(cat) for substrates with a P2 proline. The allosteric effect of the IgG is altered by deletion of Pro-60b, Pro-60c, and Trp-60d from the 60-loop of thrombin, which lies between exosite II and the catalytic triad. The effect of the IgG, however, does not depend on the presence or absence of sodium ions, a known allosteric regulator of thrombin. The IgG does not affect the conformation of thrombin exosite I as determined by binding of a fluorescent derivative of hirudin(54-65). These results provide evidence for a direct allosteric linkage between exosite II and the catalytic site of thrombin.
引用
收藏
页码:15057 / 15065
页数:9
相关论文
共 57 条
[11]   CHARACTERIZATION OF A FUNCTIONAL THROMBIN RECEPTOR - ISSUES AND OPPORTUNITIES [J].
COUGHLIN, SR ;
VU, TKH ;
HUNG, DT ;
WHEATON, VI .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :351-355
[12]   Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II [J].
Dan, JH ;
VanDeerlin, VMD ;
Tollefsen, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8243-8249
[13]   AN ALLOSTERIC SWITCH CONTROLS THE PROCOAGULANT AND ANTICOAGULANT ACTIVITIES OF THROMBIN [J].
DANG, QD ;
VINDIGNI, A ;
DICERA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :5977-5981
[14]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[15]  
DECRISTOFARO R, 1995, J MOL BIOL, V245, P447
[16]   USE OF FRAGMENTS OF HIRUDIN TO INVESTIGATE THROMBIN-HIRUDIN INTERACTION [J].
DENNIS, S ;
WALLACE, A ;
HOFSTEENGE, J ;
STONE, SR .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 188 (01) :61-66
[17]   EXPRESSION AND FOLDING OF RECOMBINANT BOVINE PRETHROMBIN-2 AND ITS ACTIVATION TO THROMBIN [J].
DIBELLA, EE ;
MAURER, MC ;
SCHERAGA, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :163-169
[18]   THE NA+ BINDING-SITE OF THROMBIN [J].
DICERA, E ;
GUINTO, ER ;
VINDIGNI, A ;
DANG, QD ;
AYALA, YM ;
WUYI, M ;
TULINSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22089-22092
[19]   CELLULAR-REGULATION OF THE PROTEIN-C PATHWAY [J].
ESMON, CT ;
FUKUDOME, K .
SEMINARS IN CELL BIOLOGY, 1995, 6 (05) :259-268
[20]   Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII [J].
Esmon, CT ;
Lollar, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13882-13887